Pfizer Goes It Alone to Expand Vaccine Business Beyond Covid-19 Pandemic – The Wall Street Journal

Pfizer Inc. aims to expand its vaccine business by becoming a leader in the new gene-based technology behind its successful Covid-19 shots.
Pfizer will develop new shots using the technology, called mRNA, to target other viruses and pathogens beyond the coronavirus, Chief Executive Albert Bourla said in an interview. He said the companys scientists and engineers gained a decades worth of experience in the past year working on the Covid-19 vaccine with Germanys BioNTech SE , and is ready to pursue…

Click here to view the original article.